PDCD1 and melanoma: Additionally, in a B16-F10 mouse melanoma model resistant to anti-PD-1 therapy with lung metastasis, a combination of lipid nanoparticles containing STING and anti-PD-1 therapy demonstrated a synergistic antitumor effect through the induction of NK cells.